Japan goes mild. The US goes actives.

In one breath. At COSME Week Osaka a speaker from @cosme put one number on the screen: 45.3% of @cosme members now agree that even if a product works well, they do not want one that stings, up 12.5 points in six months. The routine I read about online the same week was 20% azelaic acid in the morning and tretinoin at night. Two markets, two definitions of the word "works". Underneath both sits the same biology: a sting is a nerve reporting irritation, not a result, and a barrier that is not inflamed is the precondition for any active to do anything at all.

This is the first Journal post where every section carries an evidence label: 企業発表 (company data), 講演者の観測 (speaker's view), 研究知見 (research), 私の読み (my read). The habit is borrowed, with thanks, from 竹岡篤史さん (Skincare Ingredient Hunter), whose COSME Week deck labelled every slide of a 63-page talk. From now on, when I show you a number, you will know what kind of number it is.

The number · 企業発表 company data

The survey is istyle's, the company behind @cosme, Japan's largest beauty review platform. In April 2026 they asked 5,695 members to agree or disagree with a list of statements. One of them was 「たとえ効果が高くても、刺激があるものは使用したくない」: "even if it works well, I do not want to use something that stings." 45.3% agreed. Six months earlier, by the speaker's own figure, that number had been 12.5 points lower, which puts it at about 32.8%.

Figure 1. The line @cosme members agreed with, and the six-month jump. The 32.8% is derived from the stated rise, not a separately published figure.

Two caveats that belong next to the number, not under it. @cosme members are people who review cosmetics online; they are not a sample of Japan. And a twelve-point move in six months is large for a survey of this kind, which is exactly why the speaker built her talk around it.

Her reading · 講演者の観測 speaker's view

The thesis from the stage was simple and, I think, honest about what it was. Unsettled times make people conservative. Conservative people buy conservative skincare: low irritation, barrier first, nothing that announces itself on the face in the morning. In a year of price rises and political noise, 低刺激 moved from a niche promise to the main thing on the shelf.

That is an observation, not a measurement. It fits the data; it is not proven by the data. Labelled as such.

Meanwhile, the other definition of "works" · 私の読み my read

I read the US skincare internet the way I read the Japanese shelf, as a sample. The routine that keeps coming back in 2026 is a morning of 20% azelaic acid, an evening of tretinoin, with "stacking" as the new word for adding a third thing on top. Percentages are the vocabulary. Purging is a phase, not a warning. A tingle is reassurance.

Figure 2. The same word, two markets. Both definitions are measurable. They are different endpoints.

In Japan, "works" means I can use this every day, for years, and my skin is quietly better for it. In the US, "works" means I can see a change by week eight. Neither is wrong. They are different endpoints, and a product page almost never tells you which one it means.

What a sting actually is · 研究知見 research

Burning and tingling on application are sensory nerves in the skin reporting irritation. The lactic acid "sting test", used since the 1970s to identify sensitive skin, treats stinging as a marker of a reactive barrier, not as a sign that anything useful is happening underneath. A tingle tells you about your nerve endings. It says nothing about collagen, pigment or a wrinkle.

The second half matters more. An irritated stratum corneum loses more water (transepidermal water loss, TEWL, goes up), and a barrier that is losing water tolerates every subsequent active worse. This is the ordinary spiral behind "my skin can't handle anything any more": the strong routine disturbs the barrier, the disturbed barrier makes the routine sting, and the sting is read as proof the routine is working. Calm skin is not the opposite of an effective routine. It is the precondition for one.

Textbook skin physiology, not a new finding. Education, not medical advice.

Mild is not weak. Boring is not inert. · 私の読み my read

It would be easy to read the @cosme number as Japan giving up on results. The shelf says otherwise. Japanese brands did not drop the actives; they lowered the dose and wrapped them: encapsulated retinol, vitamin C derivatives rather than L-ascorbic acid, niacinamide, azelaic acid at cosmetic concentrations. Part of this is regulatory. Japanese cosmetic and quasi-drug claims are capped by law, and the famous 「角層まで」 (as far as the stratum corneum) convention means a product cannot promise to reach the dermis whatever it contains. Part of it is culture. Part of it is the market telling brands, in survey numbers, that it will pay for comfort.

So the honest sentence for each market is different. Japan: "you will still be using this in two years." The US: "you will see it in eight weeks." Both are testable. A brand that confuses them, in either direction, is the brand that gets reviewed badly abroad.

Which "works" did you mean?

The three questions I ask every label that claims to work, in any country:

1. What is the endpoint? A measurement on skin, or a feeling in a questionnaire? Both are data. Only one is a result.
2. Over what time? Eight weeks in a trial, or every day for two years in a bathroom? The second is the Japanese definition, and it is a legitimate one.
3. On whose skin? A trial panel of thirty, or 5,695 survey answers? Neither is you. Both tell you something, as long as you know which you are looking at.

If the label cannot answer all three, the percentage on the front is a marketing number, not a biology number.

Calm skin first. Then the actives. In that order, in both countries.

Keep reading

• What I check when I read a skincare claim, the method behind every post here.
• Salmon DNA, and the 500 dalton problem, on why size decides what a serum can do.
• Calecim, read like a paper, a stem cell cream and the trial that could not tell it from the vehicle.

Sources. istyle (@cosme) member survey, April 2026, n = 5,695, as presented by 原田彩子 (istyle) at the COSME Week Osaka seminar, October 1, 2026; the 32.8% is the published 45.3% minus the stated 12.5-point rise. Frosch PJ, Kligman AM. A method for appraising the stinging capacity of topically applied substances. J Soc Cosmet Chem 1977;28:197-209 (the lactic acid sting test). Elias PM. Stratum corneum defensive functions: an integrated view. J Invest Dermatol 2005;125:183-200 (barrier and TEWL). Evidence-label habit: 竹岡篤史, Skincare Ingredient Hunter, COSME Week Osaka seminar, October 1, 2026. Education, not medical advice.